Info

Banyan Biomarkers is the leader in developing in vitro diagnostic products to address unmet clinical needs for the detection of traumatic brain injury (TBI). Currently, no simple point-of-care blood test exists for use by physicians in the emergency room or in the hospital to detect the presence and severity of brain trauma. Banyan research has identified unique and proprietary biomarkers present in the patient's blood following injury to the brain. Detecting these biomarkers will provide early indications of brain trauma essential for earlier intervention and management.